Impra Carboflo
This product is designed to reduce early graft failure caused by thrombosis and offers cost-effective alternatives to pharmacological grafts, with proven clinical outcomes in below-knee popliteal and distal bypass.
- The description claims that the product reduces early graft failure due to thrombosis.
- The description claims that it is a cost-effective alternative to pharmacological grafts.
- The description claims that it has proven clinical outcomes in below-knee popliteal and distal bypass.
Specifications
- SIZE
- 6mm x 50cm, 6mm x 80cm, 6-4mm x 40cm
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
63%